1. Increased ABCC4 Expression Induced by ERRĪ± Leads to Docetaxel Resistance via Efflux of Docetaxel in Prostate Cancer
    Houbao Huang et al, 2020, Frontiers in Oncology CrossRef
  2. Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance
    Joshua Altschuler et al, 2021, International Journal of Molecular Sciences CrossRef
  3. Combined Therapies with Taxane-Based Chemotherapeutic Drugs in Prostate Cancer: Novel Insights and Future Directions
    Rafaella S. Coelho et al, 2023, BioChem CrossRef
  4. Long Non-coding RNA CDKN2B Antisense RNA 1 Gene Contributes to Paclitaxel Resistance in Endometrial Carcinoma
    Chao Shang et al, 2019, Frontiers in Oncology CrossRef
  5. Multidrug resistance-associated protein 4 in pharmacology: Overview of its contribution to pharmacokinetics, pharmacodynamics and pharmacogenetics
    Joseph Berthier et al, 2019, Life Sciences CrossRef
  6. Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
    Brandon Bumbaca et al, 2018, Acta Pharmaceutica Sinica B CrossRef
  7. Role of multidrug resistance-associated proteins in cancer therapeutics: past, present, and future perspectives
    Ahmed Elfadadny et al, 2021, Environmental Science and Pollution Research CrossRef
  8. Novel thermoresponsive star-liked nanomicelles for targeting of anticancer agent
    Aliyeh Ghamkhari et al, 2018, European Polymer Journal CrossRef